Both of these glioblastomas with heterozygous MSH6 mutations had low somatic mutation burden with TMB values of less than 5 mutations per Mb, and both were microsatellite stable with instability at less than 2% of the 86 evaluated microsatellites. This evidence concerns the gene MSH6 and glioblastoma.